• The Group
  • News and Events
  • Investor relations
    • Financial Information
      • Financial Reports
      • Financial Calendar
    • Directors
      • Executive Management
      • Board
    • Stock Information
      • Analyst Coverage
      • Stock Charts
    • Shareholder Information
      • General Meetings
      • Other Regulated Information
    • Advisor & Investor Contact
      • Investor Contacts
      • Advisors
    • Other Information
      • AIM Admission Document
      • AIM Rule 26
      • Investor Presentation
  • Careers
  • Contact
  • Corporate Presentations
    • Annual Report 2020
    • Investor Presentation 2020
    • Investor Event 2021
    • Investor Event Q&A 2021
English

Choose your language:

  • Français
23/02/17Posted in Board, Novacyt Group, Products

NOVAprep® Regulatory Update in US and China Expands Commercial Reach

Novacyt – NOVAprep® Regulatory Update in US and China ENGLISH

Paris, France and Cambridge, UK – 23rd February 2017 – Novacyt (ALTERNEXT: ALNOV), an international specialist in clinical diagnostics, today announces a regulatory update for its next generation NOVAprep® technology platform in the US and China.

© 2021 Novacyt Group.   Privacy | Copyright | Terms and Conditions
  • Connect with us